Alexion Pharma recalls
certain lots of intravenous drug Soliris
Send a link to a friend
[June 02, 2014]
- Alexion Pharmaceuticals
Inc said it is voluntarily recalling certain lots of
Soliris, an intravenous drug for two potentially fatal
blood disorders that can damage the kidneys, heart and
The company said the recall was related to its earlier manufacturing
process, which had prompted a similar recall in November.
Alexion initiated the recall due to the presence of visible
particles found in a single lot of Soliris during a test, the
company said in a statement.
The company said it did not expect the recall to have any financial
impact or interrupt supply of the drug.
(Reporting by Sruthi Ramakrishnan in Bangalore, Editing by Simon
[to top of second column]
[© 2014 Thomson Reuters. All rights
Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.